advertisement

Topcon

Zhang F 13

Showing records 1 to 13 | Display all abstracts from Zhang F

104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Yang Y
BMC Ophthalmology 2022; 22: 249
105110 Elevated IOP Alters the Material Properties of Sclera and Lamina Cribrosa in Monkeys
Jia X; Zhang F
Disease markers 2022; 2022: 5038847
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Huang X
BMC Ophthalmology 2022; 22: 249
105110 Elevated IOP Alters the Material Properties of Sclera and Lamina Cribrosa in Monkeys
Cao M
Disease markers 2022; 2022: 5038847
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Liao S
BMC Ophthalmology 2022; 22: 249
105110 Elevated IOP Alters the Material Properties of Sclera and Lamina Cribrosa in Monkeys
Pan Z
Disease markers 2022; 2022: 5038847
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Zhang F
BMC Ophthalmology 2022; 22: 249
105110 Elevated IOP Alters the Material Properties of Sclera and Lamina Cribrosa in Monkeys
Liu K
Disease markers 2022; 2022: 5038847
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Shi J
BMC Ophthalmology 2022; 22: 249
105110 Elevated IOP Alters the Material Properties of Sclera and Lamina Cribrosa in Monkeys
Zhou D
Disease markers 2022; 2022: 5038847
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Duan X
BMC Ophthalmology 2022; 22: 249
105110 Elevated IOP Alters the Material Properties of Sclera and Lamina Cribrosa in Monkeys
Duan X
Disease markers 2022; 2022: 5038847
104312 Micropulse laser trabeculoplasty on Chinese patients with glaucoma or ocular hypertension: average 35 months follow-up results
Liu K
BMC Ophthalmology 2022; 22: 249

Issue 23-2

Change Issue


advertisement

Oculus